ursolic acid has been researched along with B16 Melanoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Hata, K; Hori, K; Takahashi, S | 1 |
| Bae, JE; Chang, JH; Cho, DH; Choi, DS; Jo, DS; Kim, JB; Park, HJ; Park, NY; Shin, JJ | 1 |
| Junco, JJ; Kim, DJ; Liang, H; Malik, G; Mancha-Ramirez, A; Slaga, TJ; Wei, SJ | 1 |
| Chen, Y; Jiang, W; Li, Y; Ou, M; Shao, J; Wang, L; Wu, F; Wu, Q; Xu, Y; Yang, X; Zhang, YJ; Zheng, Q; Zou, W | 1 |
| Baishya, R; Debnath, MC; Ganguly, S; Gupta, A; Kumar, D; Nayak, DK; Sinha, S | 1 |
| Cheng, W; Dahmani, FZ; Wu, Y; Xiong, H; Yao, J; Yin, L; Zhang, J; Zhou, J | 1 |
| Kanjoormana, M; Kuttan, G | 1 |
| Cook-Moreau, J; Delage, C; Duval, RE; Liagre, B; Limami, Y; Micallef, L; Pinon, A; Simon, A | 1 |
| Kim, ST; Kim, SY; Koh, SJ; Nam, WS; Park, JW; Park, KM; Tak, JK | 1 |
| Kuttan, G; Manu, KA | 1 |
| Chulia, AJ; Delage, C; Es-saady, D; Maurizis, JC; Ollier, M; Simon, A | 1 |
11 other study(ies) available for ursolic acid and B16 Melanoma
| Article | Year |
|---|---|
Differentiation- and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line.
Topics: Animals; Apoptosis; Betulinic Acid; Cell Differentiation; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Mice; Molecular Structure; Oxidation-Reduction; Pentacyclic Triterpenes; Pyridinium Compounds; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured | 2002 |
Ursolic acid inhibits pigmentation by increasing melanosomal autophagy in B16F1 cells.
Topics: alpha-MSH; Animals; Autophagy; Cell Line, Tumor; Melanins; Melanoma, Experimental; Melanosomes; Mice; Skin Pigmentation; Triterpenes; Ursolic Acid | 2020 |
Ursolic acid and resveratrol synergize with chloroquine to reduce melanoma cell viability.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Cell Line, Tumor; Cell Survival; Chloroquine; Drug Synergism; Humans; Melanoma, Experimental; Mice; Resveratrol; Signal Transduction; Skin Neoplasms; Stilbenes; Triterpenes; Ursolic Acid | 2015 |
Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Design; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; HT29 Cells; Humans; MCF-7 Cells; Melanoma, Experimental; Mice; Structure-Activity Relationship; Triterpenes; Ursolic Acid | 2015 |
Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Drug Carriers; Drug Liberation; Emulsions; Lactic Acid; Melanoma, Experimental; Mice; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Radiopharmaceuticals; Rats, Sprague-Dawley; Surface Properties; Technetium; Tissue Distribution; Triterpenes; Ursolic Acid | 2016 |
Anti-angiogenic activity and antitumor efficacy of amphiphilic twin drug from ursolic acid and low molecular weight heparin.
Topics: Angiogenesis Inhibitors; Animals; Anticoagulants; Body Size; Collagen; Drug Combinations; Female; Glycoconjugates; Heparin, Low-Molecular-Weight; Human Umbilical Vein Endothelial Cells; Humans; Injections, Intravenous; Laminin; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Micelles; Nanoparticles; Neovascularization, Pathologic; Particle Size; Proteoglycans; Surface-Active Agents; Triterpenes; Tumor Burden; Ursolic Acid | 2017 |
Antiangiogenic activity of ursolic acid.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Proliferation; Cytokines; Endothelial Cells; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Nitric Oxide; Rats; Rats, Sprague-Dawley; Triterpenes; Umbilical Veins; Ursolic Acid; Vascular Endothelial Growth Factor A | 2010 |
A novel form of melanoma apoptosis resistance: melanogenesis up-regulation in apoptotic B16-F0 cells delays ursolic acid-triggered cell death.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Melanins; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Oxidoreductases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triterpenes; Up-Regulation; Ursolic Acid | 2011 |
Sensitization of ionizing radiation-induced apoptosis by ursolic acid.
Topics: Adenocarcinoma; Animals; Apoptosis; Cell Line, Tumor; Chemoradiotherapy; Colonic Neoplasms; Combined Modality Therapy; DNA Fragmentation; DNA, Neoplasm; Drug Screening Assays, Antitumor; Lipid Peroxidation; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Oxidation-Reduction; Prostatic Neoplasms; Radiation-Sensitizing Agents; Triterpenes; Ursolic Acid | 2012 |
Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-kappaB mediated activation of bcl-2 in B16F-10 melanoma cells.
Topics: Activating Transcription Factor 2; Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Cytokines; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Genes, p53; Granulocyte-Macrophage Colony-Stimulating Factor; Melanoma, Experimental; Mice; NF-kappa B; Triterpenes; Ursolic Acid | 2008 |
Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Division; Melanoma, Experimental; Mice; Triterpenes; Tumor Cells, Cultured; Ursolic Acid | 1996 |